[Therapeutic activity of aminaphthone in purpuric disorders].
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D062365:Aminobenzoates / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007868:Leg Dermatoses / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009284:Naphthols / Q000627:therapeutic use*; D011693:Purpura / Q000188:drug therapy*; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy; D013577:Syndrome; D013684:Telangiectasis / Q000188:drug therapy*; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D006490:Hemostatics; D009284:Naphthols; D062366:para-Aminobenzoates; C016217:aminaftone; D010129:4-Aminobenzoic Acid
Sull'attività terapeutica dell'aminaftone in quadri a carattere purpurico.